Showing results (531-540 of 1,030) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|October 4, 2019
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.
The Lancet. Respiratory Medicine|October 5, 2019
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trialRichard T Davey, Eduardo Fernández-Cruz, Norman Markowitz, et al.
The Lancet. Respiratory Medicine|October 5, 2019
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trialJohn H Beigel, Evgenia Aga, Marie-Carmelle Elie-Turenne, et al.
The Lancet. Respiratory Medicine|February 16, 2019
Lung function trajectories in health and diseaseAlvar Agusti, Rosa Faner
The Lancet. Respiratory Medicine|February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyHolly R Keir, Amelia Shoemark, Alison J Dicker, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.
The Lancet. Respiratory Medicine|October 6, 2019
Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE): a randomised controlled trialDavid R Janz, Jonathan D Casey, Matthew W Semler, et al.
The Lancet. Respiratory Medicine|August 21, 2019
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trialVikas Goyal, Keith Grimwood, Robert S Ware, et al.
The Lancet. Respiratory Medicine|April 11, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trialsFleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, et al.
Pageof 103